Results 51 to 60 of about 111,089 (390)

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]

, 2017
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J., Bruckner, Brian A., Chuang, Joyce, Estep, Jerry D., Farrar, David J., Haas, Donald C., Horstmanshof, Douglas A., Kasirajan, Vigneshwar, Lee, Sangjin, Long, James W., Milano, Carmelo A., Rogers, Joseph G., Selzman, Craig H., Shah, Keyur B., Starling, Randall C., Stehlik, Josef   +15 more
core   +2 more sources

Left Ventricular Assist Device Outflow Graft Obstruction: A Case Series.

ASAIO journal (1992), 2020
Dysfunction of different components within continuous-flow (CF) left ventricular assist device (LVAD) systems may cause adverse cardiovascular and end-organ sequelae. Outflow graft obstruction is a recognized type of LVAD component dysfunction.
S. Nathan, A. Ghotra, K. Rajagopal, Chandni Patel, Sachin Kumar, M. Patel, Ismael A. Salas de Armas, M. Jumean, M. Akay, B. Akkanti, B. Kar, I. Gregoric   +11 more
semanticscholar   +1 more source

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +1 more source

Cardiovascular prevention and rehabilitation for patients with ventricular assist device From exercise therapy to long-term therapy Part I: exercise therapy

Monaldi Archives for Chest Disease, 2015
In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are ...
Ugo Corrà, Massimo Pistono, Alessandro Mezzani, Marco Gnemmi, Franco Tarro Genta, Roberto Caruso, Pantaleo Giannuzzi   +6 more
doaj   +1 more source

Cavopulmonary assist for the failing Fontan circulation: impact of ventricular function on mechanical support strategy [PDF]

, 2014
Mechanical circulatory support--either ventricular assist device (VAD, left-sided systemic support) or cavopulmonary assist device (CPAD, right-sided support)--has been suggested as treatment for Fontan failure.
Chen, Jun, Frankel, Steven C., Giridharan, Guruprasad A., Ising, Mickey, Koenig, Steven C., Rodefeld, Mark D., Sobieski, Michael A.   +6 more
core   +1 more source

Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation

ESC Heart Failure, 2020
This study investigated outcomes after continuous flow left ventricular assist device (CF‐LVAD) implantation as bridge to heart transplantation (BTT) in advanced heart failure patients stratified by race.
A. Okoh, Mariam Selevanny, Supreet Singh, S. Hirji, Swaiman Singh, Nawar Al Obaidi, L. Lee, M. Camacho, M. Russo   +8 more
semanticscholar   +1 more source

Left ventricular assist devices: a kidney’s perspective [PDF]

Heart Failure Reviews, 2015
The left ventricular assist device (LVAD) has become an established treatment option for patients with refractory heart failure. Many of these patients experience chronic kidney disease (CKD) due to chronic cardiorenal syndrome type II, which is often alleviated quickly following LVAD implantation.
Tromp, T R, de Jonge, N, Joles, J A
openaire   +4 more sources

Hyperkalemia in Patients With Left Ventricular Assist Devices

Circulation Reports, 2021
Background: Both hypo- and hyperkalemia are associated with adverse events in heart failure patients. Their effects on patients with left ventricular assist devices (LVADs) remains unknown. Methods and Results: The cohort included consecutive patients undergoing LVAD implantation between 2014 and 2018.
Imamura, Teruhiko, Narang, Nikhil, Combs, Pamela, Siddiqi, Umar, Stonebraker, Corinne, Jeevanandam, Valluvan   +5 more
openaire   +5 more sources

Simulation of dilated heart failure with continuous flow circulatory support [PDF]

, 2014
Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation.
A Ferreira, AG Rose, AM Katz, Antonio Ferreira, B Zaret, Bradley Keller, D Burkhoff, D Chung, D Morley, DA Kass, DJ Farrar, F Moscato, G Kovacs, H Schima, H Suga, I Nordenfelt, J Gorcsan III, J Ross, James Antaki, JC Matthews, John Gorcsan, JR Fitzpatrick III, JR Fitzpatrick III, KW Gwak, KW Gwak, LA Soloff, LW Stevenson, M Kinoshita, M Palardy, M Ursino, M Vollkron, MA Simon, MS Slaughter, Natasha Loghmanpour, NC Dang, O Lisy, PK Nair, RE Ehrsam, RL Kormos, RL Kormos, S Maybaum, S Nakatani, S Vandenberghe, SG Shroff, SJ Sarnoff, Stijn Vandenberghe, U Thadani, Vincenzo Lionetti, W Little, Y Shi, Yajuan Wang   +50 more
core   +4 more sources

Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates

Circulation: Heart Failure, 2019
Background: Left ventricular assist device (LVAD) therapy improves the hemodynamics of advanced heart failure patients. However, it is unknown whether hemodynamic optimization improves clinical outcomes.
T. Imamura, V. Jeevanandam, Gene Kim, J. Raikhelkar, N. Sarswat, S. Kalantari, Bryan A. Smith, D. Rodgers, S. Besser, B. Chung, A. Nguyen, N. Narang, T. Ota, T. Song, Colleen Juricek, M. Mehra, M. Costanzo, U. Jorde, D. Burkhoff, G. Sayer, N. Uriel   +20 more
semanticscholar   +1 more source